Aneurysm of the descending thoracic aorta, ruptured
Methodology & AI Transparency ⓘ
Aneurysm of the descending thoracic aorta, ruptured Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Aneurysm of the descending thoracic aorta, ruptured is an ICD-10-CM indexed diagnosis (I71.13) within High Blood Pressure & Vascular Health.
- 2 Real-world patient consensus: Mapped to High Blood Pressure & Vascular Health under ICD-10-CM I71.13 for Aneurysm of the descending thoracic aorta, ruptured clinical workups.
- 3 Typical cash cost range: Clinicians assessing Aneurysm of the descending thoracic aorta, ruptured focus on Virchow triad prothrombotic in Aneurysm of the descending thoracic aorta, ruptured (I71.13: shear stress) and targeted history.
- 4 Top reported side effects / signs: Key Blood Pressure biomarkers for Aneurysm of the descending thoracic aorta, ruptured (I71.13): Serum Creatinine & in Aneurysm of the descending thoracic aorta, ruptured (I71.13: Potassium) & Urine Albumin-to-Creatinine Ratio [Aneurysm of the descending thoracic aorta, ruptured I71.13] (< 15 mg/g (I71.13)).
Ask our AI Specialists anything about Aneurysm of the descending thoracic aorta, ruptured
What Is Aneurysm of the descending thoracic aorta, ruptured?
Aneurysm of the descending thoracic aorta, ruptured is an ICD-10-CM indexed diagnosis (I71.13) within High Blood Pressure & Vascular Health. Clinical evaluation centers on renal-electrolyte panels [Aneurysm of the descending thoracic aorta, ruptured I71.13] alongside serial Serum Creatinine & in Aneurysm of the descending thoracic aorta, ruptured (I71.13: Potassium) tracking (K+ 4.0 – 4.8 mEq/L (I71.13)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
Aneurysm of the descending thoracic aorta, ruptured (I71.13) alters blood pressure homeostasis through Virchow triad prothrombotic in Aneurysm of the descending thoracic aorta, ruptured (I71.13: shear stress); clinical remission targets Urine Albumin-to-Creatinine Ratio [Aneurysm of the descending thoracic aorta, ruptured I71.13] within < 15 mg/g (I71.13).
Common Symptoms & Clinical Signs
- • Presentation of Aneurysm of the descending thoracic aorta, ruptured (I71.13): persistently elevated home in Aneurysm of the descending thoracic aorta, ruptured (I71.13: or clinic blood)
- • Secondary Aneurysm of the descending thoracic aorta, ruptured clinical sign: morning occipital headache, in Aneurysm of the descending thoracic aorta, ruptured (I71.13: pulsatile tinnitus, or)
- • Symptom flares in Aneurysm of the descending thoracic aorta, ruptured correlating with Serum Creatinine & in Aneurysm of the descending thoracic aorta, ruptured (I71.13: Potassium) deviation outside K+ 4.0 – 4.8 mEq/L (I71.13)
- • Functional blood pressure impact requiring renal-electrolyte panels [Aneurysm of the descending thoracic aorta, ruptured I71.13] evaluation (I71.13)
Aneurysm of the descending thoracic aorta, ruptured Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I71.13 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Serum Creatinine & in Aneurysm of the descending thoracic aorta, ruptured (I71.13: Potassium) | K+ 4.0 – 4.8 mEq/L (I71.13) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Aneurysm of the descending thoracic aorta, ruptured I71.13] | < 15 mg/g (I71.13) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Home Seated Blood in Aneurysm of the descending thoracic aorta, ruptured (I71.13: Pressure) | < 120/75 mmHg (I71.13) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Aneurysm of the descending thoracic aorta, ruptured
Treatment selection for Aneurysm of the descending thoracic aorta, ruptured depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Aneurysm of the descending thoracic aorta, ruptured)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after: What a 221-Participant Study Found Clazosentan significantly reduced the combined incidence of vasospasm-related morbidity and all-cause mortality post-aSAH with no unexpected safety findings. Journal of neurosurgery • 2022-12-01 • Phase III Randomized Trial | N = 221 | 88/100 | PMID 35364589 ↗ |
| Can This Approach Help? Inside the Latest Research on Therapies between fixed-dose telmisartan/hydrochlorothiazide and Blood-pressure-lowering efficacy was similar between the 2 regimens throughout 24 hours, despite different elimination half-lives of telmisartan and losartan. International heart journal • 2009-01-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 19246849 ↗ |
| Can This Approach Help? Inside the Latest Research on A trial of telmisartan prevention of heart and blood vessel diseases This study provided the first evidence that ARB treatment caused a smaller increase in plasma BNP and a greater decrease in UACR than non-ARB treatment, independently of blood pressure control, and gives a novel. European journal of preventive cardiology • 2016-06-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 26324672 ↗ |
Aneurysm of the descending thoracic aorta, ruptured Patient Community & “People Like Me” Threads
Filter Aneurysm of the descending thoracic aorta, ruptured community threads and patient logs by age, biological sex, dosage, and treatment duration.